TrialAnnals of oncology : official journal of the European Society for Medical Oncology2019

Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response.

J E Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.